NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) —
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Neumora Therapeutics, Inc. (NASDAQ: [...] Read more »
NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) —
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Neumora Therapeutics, Inc. (NASDAQ: [...] Read more »
NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) —
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of TransMedics Group, Inc. (NASDAQ: [...] Read more »
MNV–201 is Minovia’s second generation mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with allogeneic mitochondria
Read more »
Read more »
ZURIQUE, April 03, 2025 (GLOBE NEWSWIRE) — À medida que as abordagens convencionais falham, Free Global Cities: The Future Leaders in Migration and Public Governance propõe uma alternativa [...] Read more »
ZURICH, April 03, 2025 (GLOBE NEWSWIRE) — As conventional approaches fail, Free Global Cities: The Future Leaders in Migration and Public Governance proposes a bold alternative — autonomous cities [...] Read more »
ZÜRICH, April 03, 2025 (GLOBE NEWSWIRE) — Mit dem Scheitern konventioneller Ansätze stellt Free Global Cities: The Future Leaders in Migration and Public Governance eine mutige Alternative vor: [...] Read more »
ZURICH, 03 avr. 2025 (GLOBE NEWSWIRE) — Face à l’échec des approches conventionnelles, Free Global Cities: The Future Leaders in Migration and Public Governance propose une [...] Read more »
By External Source
Apr 3 2025 (IPS-Partners) [...] Read more »
Displaced people [...] Read more »